AstraZeneca should know by year-end whether coronavirus vaccine works if trials restart

AstraZeneca should know by year-end whether coronavirus vaccine works if trials restart



AstraZeneca should still know before the end of the year whether its experimental vaccine protects people against COVID-19, the drugmaker’s chief executive Pascal Soriot said on Thursday, as long as it can resume trials soon.